|
|
News Breaks | | | | January 24, 2013 | | 11:50 EDT |  | EXEL | Exelixis announces availability of COMETRIQ in the U.S.
Exelixis announced the commercial availability of COMETRIQ for the treatment of patients with progressive, metastatic medullary thyroid cancer. The U.S. FDA approved COMETRIQ on November 29, 2012. COMETRIQ is being distributed exclusively through Diplomat Specialty Pharmacy in the U.S. | |
|
News For EXEL From The Last 14 Days Check below for free stories on EXEL the last two weeks. |
|
|
| May 14, 2013 | | 07:18 EDT |  | EXEL | BofA/Merrill to host a conference
2013 Health Care Conference is being held in Las Vegas on May 14-16. | |
|
|
|
|
|
|
